SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 27.28 |
Enterprise Value ($M) | 26.46 |
Book Value ($M) | 30.08 |
Book Value / Share | 1.60 |
Price / Book | 0.91 |
NCAV ($M) | 27.02 |
NCAV / Share | 1.44 |
Price / NCAV | 1.01 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.93 |
Return on Assets (ROA) | -0.48 |
Return on Equity (ROE) | -0.57 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.57 |
Current Ratio | 5.57 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 33.76 |
Assets | 36.83 |
Liabilities | 6.75 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -25.15 |
Net Income | -29.07 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -23.52 |
Cash from Investing | -25.97 |
Cash from Financing | 0.36 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
17,278 | 8,798 | 196.39 | |
4,368 | 11,551 | 37.81 | |
37,594 | 24,451 | 153.75 | |
4,881 | 12,476 | 39.12 | |
(click for more detail) |
Similar Companies | |
---|---|
EFTR – eFFECTOR Therapeutics, Inc. | ELDN – Eledon Pharmaceuticals, Inc. |
ELUT – Elutia Inc. | ENSC – Ensysce Biosciences, Inc. |
ENTX – Entera Bio Ltd. |
Financial data and stock pages provided by
Fintel.io